Where every heartbeat meets intelligent, safer care.
Cardiac science is rapidly evolving with the integration of artificial intelligence and genomics, opening new frontiers in the prevention, diagnosis, and management of heart disease. AI-enabled cardiac imaging and predictive risk-assessment tools are enhancing accuracy and enabling earlier interventions, while genomic insights are paving the way for more personalised, effective treatment. By combining technology with clinical expertise, cardiovascular care is shifting toward a model that not only saves lives but extends the number of healthy heart years — redefining what longevity means in cardiac health.
Equally transformative is the role of AI in emergency cardiac response and clinical decision-making, where speed and precision are critical. This year’s Cardiology track brings clinicians and technology innovators into dynamic dialogue on AI-driven structural heart interventions, electrophysiology, and predictive analytics — ensuring that advances in cardiac science translate into safer, smarter, and more sustainable patient care.
What delegates can expect:
Last year at Clinovate:
A landmark panel on Cardiovascular Innovation, Benchmarking, and Polygenic Risk featured Dr Nilesh Samani, Professor of Cardiology, University of Leicester, alongside global leaders from Solventum, Tabhi, and the Apollo Health-Tech ecosystem — plus a full agenda of live, in-box demonstrations of complex cardiovascular intervention.